Cargando…

B cell receptor signaling drives APOBEC3 expression via direct enhancer regulation in chronic lymphocytic leukemia B cells

Constitutively activated B cell receptor (BCR) signaling is a primary biological feature of chronic lymphocytic leukemia (CLL). The biological events controlled by BCR signaling in CLL are not fully understood and need investigation. Here, by analysis of the chromatin states and gene expression prof...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Zhiquan, Yan, Huihuang, Boysen, Justin C., Secreto, Charla R., Tschumper, Renee C., Ali, Dania, Guo, Qianqian, Zhong, Jian, Zhou, Jiaqi, Gan, Haiyun, Yu, Chuanhe, Jelinek, Diane F., Slager, Susan L., Parikh, Sameer A., Braggio, Esteban, Kay, Neil E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249768/ https://www.ncbi.nlm.nih.gov/pubmed/35778390 http://dx.doi.org/10.1038/s41408-022-00690-w

Ejemplares similares

Selective Induction of DNA Repair Pathways in Human B Cells Activated by CD4(+) T Cells
por: Wu, Xiaosheng, et al.
Publicado: (2010)

Differentiation of Chronic Lymphocytic Leukemia B Cells into Immunoglobulin Secreting Cells Decreases LEF-1 Expression
por: Gutierrez, Albert, et al.
Publicado: (2011)

Stage-Specific Non-Coding RNA Expression Patterns during In Vitro Human B Cell Differentiation into Antibody Secreting Plasma Cells
por: Tschumper, Renee C., et al.
Publicado: (2022)

Upregulation of AXL and β-catenin in chronic lymphocytic leukemia cells cultured with bone marrow stroma cells is associated with enhanced drug resistance
por: Sinha, Sutapa, et al.
Publicado: (2021)

Multiple myeloma cell-derived microvesicles are enriched in CD147 expression and enhance tumor cell proliferation
por: Arendt, Bonnie K., et al.
Publicado: (2014)

Chronic lymphocytic leukemia cells from ibrutinib treated patients are sensitive to Axl receptor tyrosine kinase inhibitor therapy
por: Sinha, Sutapa, et al.
Publicado: (2018)

The risk of coronavirus disease 2019 (COVID-19) among individuals with monoclonal B cell lymphocytosis
por: Parikh, Sameer A., et al.
Publicado: (2022)

Role of long non-coding RNAs in disease progression of early stage unmutated chronic lymphocytic leukemia
por: Tschumper, Renee C., et al.
Publicado: (2019)

APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells
por: Bogerd, Hal P., et al.
Publicado: (2006)

APOBEC3B reporter myeloma cell lines identify DNA damage response pathways leading to APOBEC3B expression
por: Yamazaki, Hiroyuki, et al.
Publicado: (2020)

Associations of history of vaccination and hospitalization due to infection with risk of monoclonal B-cell lymphocytosis
por: Boddicker, Nicholas J., et al.
Publicado: (2022)

DHX9 interacts with APOBEC3B and attenuates the anti-HBV effect of APOBEC3B
por: Chen, Yanmeng, et al.
Publicado: (2020)

DNA cytosine and methylcytosine deamination by APOBEC3B: enhancing methylcytosine deamination by engineering APOBEC3B
por: Fu, Yang, et al.
Publicado: (2015)

The CLL International Prognostic Index predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLL
por: Parikh, Sameer A., et al.
Publicado: (2021)

APOBEC3B and APOBEC mutational signature as potential predictive markers for immunotherapy response in non-small cell lung cancer
por: Wang, Shixiang, et al.
Publicado: (2018)

Roles of APOBEC3A and APOBEC3B in Human Papillomavirus Infection and Disease Progression
por: Warren, Cody J., et al.
Publicado: (2017)

Associations between the single nucleotide polymorphisms of APOBEC3A, APOBEC3B and APOBEC3H, and chronic hepatitis B progression and hepatocellular carcinoma in a Chinese population
por: He, Xiuting, et al.
Publicado: (2019)

APOBEC3B gene overexpression in non-small-cell lung cancer
por: SASAKI, HIDEFUMI, et al.
Publicado: (2014)

GATA3 and APOBEC3B are prognostic markers in adrenocortical carcinoma and APOBEC3B is directly transcriptionally regulated by GATA3
por: Gara, Sudheer Kumar, et al.
Publicado: (2020)

Structural basis for targeted DNA cytosine deamination and mutagenesis by APOBEC3A and APOBEC3B
por: Shi, K., et al.
Publicado: (2016)

Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer
por: Nik-Zainal, Serena, et al.
Publicado: (2014)

Involvement of APOBEC3B in mutation induction by irradiation
por: Saito, Yohei, et al.
Publicado: (2020)

Genetic inhibitors of APOBEC3B-induced mutagenesis
por: Mertz, Tony M., et al.
Publicado: (2023)

An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers
por: Chan, Kin, et al.
Publicado: (2015)

Exploring APOBEC3A and APOBEC3B substrate specificity and their role in HPV positive head and neck cancer
por: Papini, Christina, et al.
Publicado: (2022)

APOBEC3A/B deletion polymorphism and cancer risk
por: Gansmo, Liv B, et al.
Publicado: (2018)

APOBEC3B: Future direction of liver cancer research
por: Yang, Xingyue, et al.
Publicado: (2022)

The APOBEC3B cytidine deaminase is an adenovirus restriction factor
por: Lejeune, Noémie, et al.
Publicado: (2023)

APOBEC3B Is Co-Expressed with PKCα/NF-κB in Oral and Oropharyngeal Squamous Cell Carcinomas
por: Fanourakis, Galinos, et al.
Publicado: (2023)

Endogenous APOBEC3B Overexpression Constitutively Generates DNA Substitutions and Deletions in Myeloma Cells
por: Yamazaki, Hiroyuki, et al.
Publicado: (2019)

Distinctive High Expression of Antiretroviral APOBEC3 Protein in Mouse Germinal Center B Cells
por: Tsukimoto, Shota, et al.
Publicado: (2022)

Aberrant APOBEC3B Expression in Breast Cancer Is Linked to Proliferation and Cell Cycle Phase
por: Roelofs, Pieter A., et al.
Publicado: (2023)

TALEN-mediated genetic tailoring as a tool to analyze the function of acquired mutations in multiple myeloma cells
por: Wu, X, et al.
Publicado: (2014)

Comprehensive Assessment of Potential Multiple Myeloma Immunoglobulin Heavy Chain V-D-J Intraclonal Variation Using Massively Parallel Pyrosequencing
por: Tschumper, Renee C., et al.
Publicado: (2012)

BE-FLARE: a fluorescent reporter of base editing activity reveals editing characteristics of APOBEC3A and APOBEC3B
por: Coelho, Matthew A., et al.
Publicado: (2018)

APOBEC3G directly binds Hepatitis B virus core protein in cell and cell free systems
por: Zhao, Dongjiu, et al.
Publicado: (2010)

Genomic Characterization of High-Count MBL Cases Indicates that Early Detection of Driver Mutations and Subclonal Expansion are Predictors of Adverse Clinical Outcome
por: Barrio, S., et al.
Publicado: (2016)

B-Myb Induces APOBEC3B Expression Leading to Somatic Mutation in Multiple Cancers
por: Chou, Wen-Cheng, et al.
Publicado: (2017)

Massive APOBEC3 Editing of Hepatitis B Viral DNA in Cirrhosis
por: Vartanian, Jean-Pierre, et al.
Publicado: (2010)

APOBEC3B, a molecular driver of mutagenesis in human cancers
por: Zou, Jun, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fe726872ulk3pf7bknfm0bkvs8